FDA Grants Full Approval to First COVID-19 Vaccine
On Monday, the U.S. Food and Drug Administration (FDA) approved the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine became the first in the nation to receive full FDA approval. The Pfizer-BioNTech vaccine continues to be available under emergency use authorization (EUA), including for…
Read More »